BACKGROUND: Screening and determining the immune status of individuals for hepatitis B is usually done by detecting hepatitis B surface antigen (HBsAg) and hepatitis B surface antigen-specific antibodies (HBsAb). In some countries with the highest viral burden, performing these assays is currently impractical. This paper explores the use of filter paper as a blood specimen transport medium. METHODS: Samples, chosen from routine clinical laboratory pool, were applied and dried onto filter paper. Eluates, from the paper samples, were analyzed as routine clinical specimens on ADVIA Centaur 5634® immunoassay analyzers using the standard HBsAg and HBsAb kits. Dried blood samples were subjected to a range of environmental conditions in order to assess stability. RESULTS: After drying and elution the assays showed linearity and precision comparable to clinical assays performed on fresh serum. Elutions at various times during a 149 day incubation period showed very little variability in the Index numbers. All analytes were temperature stable except for a decrease in the HBsAg signal at 42°C. CONCLUSIONS: Filter paper is an acceptable storage and transport medium for serum to be used in the detection of hepatitis B markers if atmospheric variability can be controlled. HBsAg, HBsAb and HBcAb are all stable for at least five months under storage conditions below room temperature. Drying specimens, particularly serum, on filter paper at remote locations, offers a reasonable solution to the problem of hepatitis surveillance in underdeveloped regions, although some attempt at temperature control might be desirable.
BACKGROUND: Screening and determining the immune status of individuals for hepatitis B is usually done by detecting hepatitis B surface antigen (HBsAg) and hepatitis B surface antigen-specific antibodies (HBsAb). In some countries with the highest viral burden, performing these assays is currently impractical. This paper explores the use of filter paper as a blood specimen transport medium. METHODS: Samples, chosen from routine clinical laboratory pool, were applied and dried onto filter paper. Eluates, from the paper samples, were analyzed as routine clinical specimens on ADVIA Centaur 5634® immunoassay analyzers using the standard HBsAg and HBsAb kits. Dried blood samples were subjected to a range of environmental conditions in order to assess stability. RESULTS: After drying and elution the assays showed linearity and precision comparable to clinical assays performed on fresh serum. Elutions at various times during a 149 day incubation period showed very little variability in the Index numbers. All analytes were temperature stable except for a decrease in the HBsAg signal at 42°C. CONCLUSIONS: Filter paper is an acceptable storage and transport medium for serum to be used in the detection of hepatitis B markers if atmospheric variability can be controlled. HBsAg, HBsAb and HBcAb are all stable for at least five months under storage conditions below room temperature. Drying specimens, particularly serum, on filter paper at remote locations, offers a reasonable solution to the problem of hepatitis surveillance in underdeveloped regions, although some attempt at temperature control might be desirable.
Hepatitis B virus is a human pathogen that infects the liver and can cause both acute
and chronic disease. More than 350 million individuals live with chronic hepatitis B
worldwide [1,2]. These
individuals are often asymptomatic but approximately 25% of adults who are
chronically infected will die of cirrhosis or hepatocellular carcinoma secondary to
the infection [3]. The best approach to
reduce the burden of hepatitis B is to prevent infection, mainly through vaccination
and infection control measures [4]. There are
also treatment options with some effectiveness that include interferon, anti-viral
drugs and in some cases liver transplants.Screening for disease and determining the immune status of individuals is usually
done by detecting hepatitis B surface antigen (HBsAg), hepatitis B surface
antigen-specific antibodies (HBsAb) and hepatitis B core antibodies (HBc). The
presence of anti-HBsAg IgG is a marker for immunity and used to determine whether a
patient needs to be vaccinated [5,6]. The most commonly used tests are immunoassays performed
on fairly complex analyzers by trained technologists [5-7]. In some
countries with the highest viral burden, such as those in sub-Saharan Africa,
performing these assays is currently impractical due to the local unavailability of
laboratory resources.Blood serum and plasma specimens have in many instances been successfully collected
and dried onto paper media for subsequent testing elsewhere [8-17]. This paper explores the use of filter paper as a
medium on which to apply and dry serum or plasma specimens in the field for safe and
convenient transport to laboratories possessing the required technology for the
testing of hepatitis B markers.
Methods
Specimen collection and immobilization onto paper
Specimens were chosen from the routine clinical laboratory at the Rochester
General Hospital for study, representing the different laboratory presentations
seen in patients, including immunization, current chronic or acute disease, and
resolved infection. The specimen collection plan was submitted and found to be
exempt from formal review by the Internal Review Board (IRB) at the Rochester
General Hospital. The Institutional Review Board deemed this study to be exempt
under Federal regulations after all patient identifiers were stripped from the
samples by a third party not involved in the research before being tested. 50
μl aliquots of the specimens were absorbed into fifteen centimeter diameter
filter paper (Reeve Angel® 230- Whatman Inc.) and allowed to dry by hanging
at ambient temperature for a day. This paper has a high absorptive capacity (5.0
ml per filter) for serum and plasma (data not shown). Dried paper was stored
individually in plastic bags at room temperature (21°C). No silica gel
desiccants were used in the plastic bags.
Disc elution
Paper discs were obtained from the filter paper by using a hand punch (M.C. Mieth
Manufacturing Inc.). Each paper disc measured 8.73 mm. The specimens were eluted
with deionized water and pH 7.2 phosphate buffered saline
(Beckman-Coulter®) in watch glasses, using the same volume of sample that
had been originally applied to the filter paper. Some discs required tamping to
insure complete elution. The discs were stacked in threes in the watch glasses
and placed into the cylinders of three milliliter disposable syringes (BD 3ml
syringe – Luer-Lok™ Tip) using metal forceps. The stacks were tapped
to the bottom of the syringes using a blunt rod, and seated flat. The discs were
eluted under gravity into 16 × 100 mm tube (Vacutainer) with no additives.
When no liquid was visible above the filter discs, final elutions were made
using the syringe plungers. The punch, watch glass, forceps and blunt rod were
thoroughly rinsed and dried between specimens.
Hepatitis B analysis and characterization
Eluates were analyzed as routine clinical specimens on ADVIA Centaur 5634®
immunoassay analyzers (Siemens) for surface antigen (HBsAg), total core antibody
(HBcAb), and surface antibody (HBsAb) following the manufacturer
recommendations. The ADVIA Centaur assays are magnetic particle
chemiluminometric immunoassays that use biotinylated mouse monoclonal capture
antibodies and acridinium-ester labeled mouse monoclonal antibodies and
streptavidin coated magnetic latex particles. The cutoff Index value for
positivity is ≥1.00 including results between 1.00-1.95 Index value which
are considered weakly reactive [18].To characterize the properties of the samples after dehydration and elution, we
performed studies of linearity, precision, and stability at different
conditions. The linearity studies were conducted using serum from two different
patients, one for antigen, and the second for the two antibodies. The high HBsAg
titer sample (26,000 relative light units in the original assay) was serially
diluted from 1:5 to 1:10,000. HBcoreTotal and HBsAB linearity studies were
performed on dilution from 1:2.5 to 1:10,000. The precision studies were
performed by making 136 punches from a saturated 15.0 cm filter. These discs
were mixed in the same plastic bag in which the filter was stored. Five groups
of fifteen random discs were removed, and the specimens were eluted and
assayed.The correlation of results was described using R-squared analysis, linear
regression and a simple degree of concordance calculation. Coefficient of
variation was defined as the ratio of the standard deviation to the mean.
Specimen source, stability and uniformity
The first stability experiments were carried out on paper saturated with a pool
containing all three markers made from different individual specimens. Samples
were kept at room temperature and assayed at one-week intervals for the first
month then monthly for four months, for the three hepatitis B markers.To determine the stability of the three markers over time at different
temperatures, a single 15 cm filter saturated with the pool was used to obtain
seventy-two filter paper discs. The discs were mixed in a plastic bag. Three
discs were placed into each of 24 glassine envelopes (Westvāco –
Envelope Division). The envelopes were stored from one day to 28 days under
following conditions: ambient temperature (77.5°F), refrigerator
temperature (4°C), freezer (−18°C), deep freeze
(−78°C), and 42°C incubator. An additional set of three discs
was exposed to gamma radiation from a cesium-source blood irradiator for seven
minutes and 12 seconds. The effect of humidity was studied by placing five 15.0
cm filter papers into environmental chambers at each of the following humidity
levels: 20%, 50% and 90%.To determine whether significant differences in analyte recovery occurred
regionally across the filter, a 15.0cm filter was divided into 8 sectors, and
each sector was subdivided into a central and a peripheral section. Including a
specimen from the actual center of the filter, a total of 17 regions were
assayed from the same original filter paper.While the assays are preferentially performed on serum specimens, we attempted to
determine the suitability of plasma and whole blood as well. Serum, plasma, and
ethylenediaminetetraacetic acid (EDTA) whole blood specimens were obtained via
venipuncture from positive patients and negative volunteers. Both plasma and
serum specimens were analyzed for baseline levels of the three analytes. Serum,
plasma, and whole blood were applied to individual filters and dried. The papers
were processed as described. Tandem samples from three patients were processed
to compare serum and plasma.
Results
Assay linearity
After drying and elution the assays showed linearity and precision comparable to
clinical assays performed on fresh serum. HBsAg testing after elution had a
dynamic range of 0.10 to 1000 Relative Light Units (RLUs; Index) with a
correlation coefficient R2 equal to 0.9992 when compared to the
results obtained from the fresh specimens. The results for HBcAb and HBsAb were
linear from 1:2.5 to 1:100 and well correlated with the previously determined
results. The dilutions from 1:250 to 1:10,000 were also statistically well
correlated (Figure 1). The coefficient of variation of the
assays was less than 10%. The HBsAg range was 17127–19494. The HBcAb range
(Index) was 105.51–114.14. The HBsAB range (Index) was
47.24–54.19.
Figure 1
HBsAg Linearity and Dynamic Range Testing Following Paper Elution.
The measured versus calculated results exhibited a correlation
coefficient (r2) of 0.9992, over a dynamic range of 0.10 to
1000 RLUs (Index), when compared to the results obtained from the fresh
specimens. The RLU-Index values are provided for comparison.
HBsAg Linearity and Dynamic Range Testing Following Paper Elution.
The measured versus calculated results exhibited a correlation
coefficient (r2) of 0.9992, over a dynamic range of 0.10 to
1000 RLUs (Index), when compared to the results obtained from the fresh
specimens. The RLU-Index values are provided for comparison.
Specimen stability
Elutions at various times during the 149 days showed very little variability in
the Index numbers produced by the assays with all three analytes being stable at
room temperature and below (−70 to 25.3°C). However, after exposure
to high atmospheric temperature (42°C) for an undetermined amount of time
signal was lost and the targets denatured to the point that they could not be
detected by the assay. Representative data for HBsAg is detailed in Figure 2. The HBsAg range was 12151–15820 RLUs. The HBcAb
range was 105.68–140.90 (RLUs). The HBsAb range was 72.04–92.09
(RLUs). The calculated coefficients of variation were less than 10%.
Figure 2
Temperature Stability of the HBsAg Assay. Comparison of signal
strength from samples stored at −78°C, -18°C, 4°C,
25.3°C and 42°C for up to 28 days. Samples stored at all
tempreatures were stable except for the samples stored at 42°C
which degraded over time.
Temperature Stability of the HBsAg Assay. Comparison of signal
strength from samples stored at −78°C, -18°C, 4°C,
25.3°C and 42°C for up to 28 days. Samples stored at all
tempreatures were stable except for the samples stored at 42°C
which degraded over time.The HBsAb values were stable at all temperatures studied. The HBcAb value was
stable at all lower temperatures, but decreased 25% at 7 days and 33% at 14 days
at 42°C. The HBsAg concentration was stable at all lower temperatures, but
showed decreases of 55% at 7 days and 68% at 14 days at 42°C.
Specimen source
The whole blood elution showed a significant increase in HBsAb, while the HbsAg
and HBcoreTotal results were unaffected by the presence of hemolysis. There was
no significant difference in the data obtained from the three humidity levels of
filter paper for HBsAg, HBsAb and HBCore Total. Identical negative results were
obtained from serum and plasma of patients with no hepatitis B markers.A mapping study (data not shown) showed little variation in HBsAg results across
all sectors tested. The range of variability went from 17% above and 13% below
the average signal value in all regions that is within acceptable performance
parameters. This variability did not affect the interpretation of results for
HBsAg.Overall, there was exact agreement in the HBsAg interpretation (positive,
negative or equivocal) between initial patient clinical results (serum
specimens) and subsequent results obtained from eluted filter papers (Figure
3 a,b). Many of the false negatives had original serum
values below 10 which is considered not immune.
Figure 3
Comparison of the (a) HBsAg (n = 63 samples) and (b) HBsAb
(n = 39 samples) interpretation (positive, negative or
equivocal) between initial patient clinical results (serum
specimens) and subsequent results obtained from eluted filter
papers. The eleven discrepant results in the HBsAb assay were
related to very low signal in the original samples.
Comparison of the (a) HBsAg (n = 63 samples) and (b) HBsAb
(n = 39 samples) interpretation (positive, negative or
equivocal) between initial patient clinical results (serum
specimens) and subsequent results obtained from eluted filter
papers. The eleven discrepant results in the HBsAb assay were
related to very low signal in the original samples.
Discussion
Filter paper is an acceptable storage and transport medium for serum to be used in
the detection of hepatitis B markers if temperature can be controlled. HBsAg, HBsAb
and HBcAb are all stable for at least five months under storage conditions at or
below 250C. The test characteristics of linearity and precision were
unchanged when compared to the assays performed on fresh serum. Humidity had no
effect on the measurements obtained. At 42°C there was a significant decrease
in the measured HBsAg. While the decrease was marked, interpretation of the Index
value did not change and the result would have still been reported as positive for
HBsAg. There was also a slightly increased coefficient of variation at 42°C
although the difference would not affect the final interpretation of the values. We
did not find a single discrepant result when compared on the basis of interpretation
(positive or negative for markers). Serum is the preferred testing sample rather
than whole blood since there is some positive bias for surface antibody when using
whole blood. This interference may be caused by hemoglobin on the filter paper.
Plasma did not show any background interference.Clearly, DBS techniques have been investigated for decades as a means of extending
the reach of clinical services into remote regions. Our results build on recent
prior studies that, collectively suggest, whole blood may be collected and
stabilized on a variety of different filter papers [14-16,19,20]. Our results also confirm that
the HBsAg, reconstituted from immobilized dried whole blood, was most sensitive to
changes in ambient temperature [20,21]. Our results, however, do provide a pathway to DBS
collection validation when coupled with the sensitive chemiluminescent immunoassay
technique. In our study, all three markers remained above the positive cutoff even
when stored at 42°C for 28 days. This period would be long enough to survive
mailing in tropical or remote regions. To our knowledge, our study is the first to
suggest that all three markers for hepatitis B may be immobilized and dried onto
filter paper, transported at elevated temperatures over an extended period of time
without refrigeration, and reconstituted to provide a positive assay using a
sensitive immunochemical analysis.
Conclusions
Drying specimens, particularly serum, on filter paper at remote locations, offers a
reasonable solution to the problem of hepatitis surveillance in underdeveloped
regions, although some attempt at temperature control might be desirable. Analytes
are stable, and the papers can be shipped to centralized facilities that have
advanced testing capabilities. Our proof-of-concept work, using an
immunofluorescence methodology remains to be validated in field trials. These field
trials are currently under way in Rwanda.
Abbreviations
DBS, Dried blood spot; HBsAg, Hepatitis B surface antigen; HBsAb, Hepatitis B surface
antibody; HBcAb, Hepatitis B core antibody.
Competing interests
The authors declare that they have no competing interests.
Authors’ contributions
TKM, RLV, LRK and SAW conceived of the study, and participated in its design and
coordination and helped to draft the manuscript. AEK and SPC designed and carried
out the filter paper immobilization and reconstitution procedures. DMC designed and
carried out the environmental studies related the impact of temperature on the
assay. DMC also designed and carried out the measurements on the physical properties
of the filter paper media. All authors read and approved the final manuscript.
Author information
TKM is the Chief of Laboratory Services and RLV is the Director of Microbiology in
the Department of Pathology and Laboratory at the Rochester General Hospital. LRK is
a physician of internal medicine and currently practices at the Shyira Hospital in
Rwanda, Africa which serves a surrounding rural population of over 200,000. SAW is a
Professor of Chemistry at RIT, and with DMC, designed and coordinated research
involving the material properties related to the paper and biomaterials used in the
study. Our multi-disciplinary team is part of the RGH-RIT collaboration between
local hospitals and academic departments.
Pre-publication history
The pre-publication history for this paper can be accessed here:http://www.biomedcentral.com/1472-6890/12/8/prepub
Authors: Eric E Mast; Harold S Margolis; Anthony E Fiore; Edward W Brink; Susan T Goldstein; Susan A Wang; Linda A Moyer; Beth P Bell; Miriam J Alter Journal: MMWR Recomm Rep Date: 2005-12-23
Authors: Livia Melo Villar; Jaqueline Correia de Oliveira; Helena Medina Cruz; Clara Fumiko Tachibana Yoshida; Elisabeth Lampe; Lia Laura Lewis-Ximenez Journal: J Med Virol Date: 2011-09 Impact factor: 2.327
Authors: M Mendy; G D Kirk; M van der Sande; A Jeng-Barry; O A Lesi; P Hainaut; O Sam; S McConkey; H Whittle Journal: J Viral Hepat Date: 2005-11 Impact factor: 3.728
Authors: Emmet B Keeffe; Douglas T Dieterich; Steven-Huy B Han; Ira M Jacobson; Paul Martin; Eugene R Schiff; Hillel Tobias; Teresa L Wright Journal: Clin Gastroenterol Hepatol Date: 2006-07-14 Impact factor: 11.382
Authors: Sarah M Lofgren; Anne B Morrissey; Caroline C Chevallier; Anangisye I Malabeja; Sally Edmonds; Ben Amos; David J Sifuna; Lorenz von Seidlein; Werner Schimana; Wendy S Stevens; John A Bartlett; John A Crump Journal: AIDS Date: 2009-11-27 Impact factor: 4.177